Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer – a propensity score matched analysis

Klinikum der Universität München AVT Chirurgie0 个研究点目标入组 82 人开始时间: 2020年5月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients undergoing pancreatic surgery at our institution between 01/2014 and 11/2016 .
•Inclusion criteria were: (1) confirmed diagnosis of pancreatic ductal adenocarcinoma (PDAC) by pathology, (2) exclusion of distant metastasis at time of surgery, (3) successful resection of primary tumor with curative intent, (4) postoperative survival and/or follow-up of at least 12 weeks, (5) disease-free survival of at least 6 weeks. Since we wanted to focus our analysis on the metastases that might be favored by the perioperative period, we excluded patients who developed metastases within the first 6 weeks after resection, as these must have presumably already existed at the time of surgery.

•Patients with diagnosis other than PDAC were excluded as well as patients that suffered from locally advanced disease that underwent neoadjuvant therapy.

发起方

Klinikum der Universität München AVT Chirurgie